Introduction to Caseous Mitral Annular Calcification

Caseous mitral annular calcification represents a rare and often misidentified variant of the more common mitral annular calcification (MAC). Specifically, this condition involves a liquefactive necrosis of a calcified mitral annulus, resulting in a mass-like lesion that can confuse even experienced clinicians. Furthermore, a 73-year-old asymptomatic obese woman recently highlighted these diagnostic challenges during a routine pre-operative cardiologic evaluation. Initially, clinicians referred her for evaluation before an elective knee arthroplasty, but transthoracic echocardiography revealed unexpected findings. Specifically, the imaging showed asymmetric left ventricular hypertrophy alongside a large, non-mobile hyperechogenic mass within the interventricular septum. Consequently, this discovery raised immediate concerns regarding a potentially malignant cardiac tumor or an infiltrative process. However, further investigation into the nature of this lesion became paramount to avoid unnecessary surgical interventions. Notably, caseous mitral annular calcification typically appears as a benign entity, yet its unusual presentation can closely mimic more aggressive pathologies. Therefore, understanding the distinct imaging signatures of this condition is essential for cardiologists and radiologists alike. In this case, the extensive involvement of the myocardium made the diagnosis particularly complex, requiring a systematic multimodality approach to confirm the benign nature of the septal mass.

Pathophysiology of Liquefactive Caseous Necrosis

The underlying pathophysiology of caseous mitral annular calcification involves a unique degenerative process that transforms a stable calcified annulus into a semi-liquid mass. Traditionally, researchers describe this material as a "toothpaste-like" mixture of calcium, cholesterol, and fatty acids. Moreover, this liquefactive necrosis typically occurs in the central portion of a large calcified area, often involving the posterior mitral annulus. Subsequently, this process creates a well-defined, ovoid mass that can expand into adjacent structures, including the myocardium and the interventricular septum. Although the exact triggers for this liquefactive transformation remain unclear, clinicians often observe it in elderly patients and those with chronic kidney disease. Additionally, the condition shows a higher prevalence in women than in men, potentially linked to hormonal influences or metabolic factors. Furthermore, the caseous material remains enclosed within a fibrous capsule, which explains why the lesion often appears stable and non-mobile during cardiac cycles. However, when the calcification extends into the myocardium, as seen in this patient, it can mimic hypertrophic cardiomyopathy or even an abscess. In fact, the presence of chronic inflammation and fibrosis around the caseous core further complicates the tissue characterization on initial imaging. Therefore, identifying the hallmark lack of internal vascularization is a critical step in the diagnostic pathway for these patients.

Multimodality Imaging Techniques and Characteristic Findings

In the management of caseous mitral annular calcification, multimodality imaging serves as the cornerstone for reaching an accurate and definitive diagnosis. Initially, transthoracic echocardiography provides the first glimpse of the lesion, typically appearing as a large echogenic mass with central echolucency. However, echocardiography alone often lacks the specificity required to rule out malignancy or infection definitively. Consequently, physicians often utilize cardiac magnetic resonance (CMR) imaging to gain deeper tissue insights. In this specific case, CMR confirmed the presence of asymmetric septal hypertrophy while identifying lesions with markedly reduced native T1 and T2 values. Furthermore, first-pass perfusion imaging demonstrated a total lack of enhancement within the core, suggesting an avascular structure. Additionally, late gadolinium enhancement (LGE) patterns revealed a thin peripheral rim of enhancement surrounding the non-enhancing core, which signifies surrounding fibrosis. Subsequently, cardiac computed tomography (CT) added further clarity by demonstrating severe calcific degeneration of the mitral annulus. Specifically, the CT scans showed the calcification extending deep into the interventricular septum and adjacent myocardium. Notably, CT remains the gold standard for identifying the high-density calcium that characterizes these lesions. Therefore, the combination of CMR's tissue characterization and CT's calcium sensitivity allows clinicians to diagnose the condition with high confidence without resorting to invasive biopsies.

Diagnostic Challenges of Caseous Mitral Annular Calcification Extension

One of the most significant diagnostic hurdles involves the intramyocardial extension of caseous mitral annular calcification, which can mimic a variety of cardiac masses. Specifically, when the calcific material infiltrates the septum or the ventricular walls, it alters the local anatomy and signal patterns. Furthermore, this extension can lead to an erroneous diagnosis of primary cardiac tumors, such as myxomas or sarcomas. In fact, the mass-like appearance within the interventricular septum in the 73-year-old patient initially suggested a neoplastic process. However, the absence of mobility and the lack of internal perfusion on imaging help differentiate this benign entity from most malignant tumors. Moreover, clinicians must also consider the possibility of a cardiac abscess, especially if the patient presents with systemic symptoms. Fortunately, the patient in this case remained asymptomatic, which made an infectious cause less likely. Additionally, the stable nature of the lesion over time is a helpful diagnostic clue. Nevertheless, the rarity of extensive myocardial involvement means that many practitioners may not immediately include caseous calcification in their differential list. Consequently, this case underscores the importance of recognizing that caseous mitral annular calcification is not always confined to the valve annulus but can involve the heart muscle extensively.

Differential Diagnosis and Systematic Exclusion Criteria

To reach a definitive diagnosis of caseous mitral annular calcification, clinicians must follow a strict process of exclusion for other metabolic and inflammatory causes. Specifically, secondary causes of myocardial calcification, such as hyperparathyroidism or chronic renal failure, must be ruled out through laboratory testing. Furthermore, inflammatory conditions like sarcoidosis or previous infectious myocarditis can sometimes leave behind calcified residues within the heart tissue. In this specific clinical scenario, the medical team systematically excluded secondary metabolic, inflammatory, ischemic, and infectious causes. Additionally, ischemic heart disease can result in dystrophic calcification of infarcted myocardium, but the distribution in this case did not follow a coronary territory. Consequently, the isolated involvement of the mitral annulus and the adjacent septum pointed directly toward caseous degeneration. Moreover, the lack of systemic inflammatory markers helped eliminate the possibility of an evolving abscess or vegetation. Notably, the distinct imaging findings on CMR, particularly the peripheral LGE and low T1/T2 signals, provided strong evidence against more common infiltrative diseases like amyloidosis. Therefore, by methodically ruling out these alternatives, the physicians confirmed the benign nature of the septal mass. Ultimately, this systematic approach ensured that the patient could proceed with her planned surgery without the fear of an underlying cardiac malignancy.

Clinical Management Strategies and Patient Outcomes

The clinical management of caseous mitral annular calcification is generally conservative, particularly for patients who remain asymptomatic and show no valvular dysfunction. Furthermore, the natural history of these lesions often involves a stable or even slightly regressive course over several years. Specifically, since the condition is benign, aggressive surgical excision is usually unnecessary and may even carry higher risks than the disease itself. However, if the caseous mass causes significant mitral regurgitation or stenosis, or if there is a high risk of embolism, surgical intervention might be considered. In this case, the 73-year-old woman maintained preserved systolic function and remained asymptomatic, leading the team to recommend a watchful waiting approach. Additionally, regular follow-up with serial echocardiography is recommended to monitor for any changes in the size of the mass or its impact on cardiac hemodynamics. Moreover, managing cardiovascular risk factors like hypertension and obesity remains a priority, as these conditions are often associated with accelerated mitral calcification. Consequently, the patient successfully underwent her elective knee arthroplasty following the cardiac clearance. This outcome demonstrates that an accurate, non-invasive diagnosis of caseous mitral annular calcification can significantly improve patient care by avoiding high-risk cardiac procedures. In conclusion, multimodality imaging remains the most powerful tool in the clinician's arsenal for managing this rare but important cardiac mass mimic.

Frequently Asked Questions

What are the hallmark features of CMAC on cardiac MRI?

On cardiac magnetic resonance imaging, caseous mitral annular calcification typically presents with very low signal intensity on both T1-weighted and T2-weighted sequences due to the dense calcium and proteinaceous material. Furthermore, first-pass perfusion imaging shows no internal enhancement, confirming the avascular nature of the lesion. Notably, late gadolinium enhancement usually reveals a well-defined peripheral rim of enhancement, which represents the surrounding fibrous capsule or inflammatory reaction around the caseous core.

How do clinicians differentiate CMAC from a cardiac abscess?

Clinicians differentiate caseous mitral annular calcification from a cardiac abscess primarily through clinical presentation and imaging characteristics. Specifically, patients with an abscess usually exhibit fever, elevated inflammatory markers, and signs of endocarditis, whereas CMAC is often an incidental, asymptomatic finding. Additionally, on imaging, an abscess typically shows central liquefaction with irregular borders and dynamic changes, while CMAC appears as a stable, well-defined mass with high-density calcification clearly visible on a CT scan.

Should asymptomatic patients with CMAC undergo surgery?

In most clinical scenarios, asymptomatic patients diagnosed with caseous mitral annular calcification do not require surgical intervention. Furthermore, because the entity is benign and frequently stable, the risks of open-heart surgery often outweigh the benefits of removing the mass. Consequently, management typically involves conservative monitoring and serial echocardiography. However, surgery may become necessary if the lesion leads to severe valvular dysfunction, systemic embolization, or if the diagnosis remains uncertain despite extensive multimodality imaging evaluations.

Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read here. Refer to the latest local and national guidelines for clinical practice.

References

Frittella S et al. Multimodality imaging of extensive caseous-calcific myocardial involvement mimicking a cardiac mass. Int J Cardiovasc Imaging. 2026 Jul 08. doi: 10.1007/s10554-026-03776-9. PMID: 42420742.

Harpaz D, Auerbach I, Vered Z, et al. Caseous calcification of the mitral annulus: a neglected, unrecognized diagnosis. J Am Soc Echocardiogr. 2001;14(8):825-831. doi: 10.1067/mje.2001.111817.

Nance JW Jr, Crane GM, Halushka MK, Fishman EK, Zimmerman SL. Myocardial calcifications: pathophysiology, etiologies, differential diagnoses, and imaging findings. J Cardiovasc Comput Tomogr. 2015;9(1):58-67. doi: 10.1016/j.jcct.2014.12.006.